🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philip Friedlander

Icahn School of Medicine at Mount Sinai

ORCID: 0000-0001-6538-1615
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478
N/A
4.0DataRank · unranked
140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Current Melanoma Treatments: Where Do We Stand?

Cancers(2021)10.3390/cancers13020221
N/A
0.606DataRank · unranked
56 citations

Lucie Heinzerling, Nina Bhardwaj, Philip Friedlander, Alvaro Moreira

Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma

Journal of Clinical Oncology(2024)10.1200/jco.24.00640
N/A
0.592DataRank · unranked
22 citations

Ramya Ramaswami, Irene Ekwede, Vanessa Eulo, Gaurav Goyal, Manoj Menon +22 more

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1898105
N/A
0.489DataRank · unranked
25 citations

Hassane M. Zarour, Hussein A. Tawbi, John M. Kirkwood, Michael A. Postow, Philip Friedlander +11 more

Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009609
N/A
0.104DataRank · unranked
1 citations

Allison L. Richards, Philip Friedlander, Jedd D. Wolchok, Andrea P. Moy, Alexander N. Shoushtari +1 more

Supplementary Figure 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

(2023)10.1158/2326-6066.22537789
N/A
0DataRank · unranked
0 citations

Donald P. Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada +18 more